Phebra’s objective 

To expand its capabilities across all facets of their business, including R&D, testing, non-sterile manufacturing and packaging.


Phebra is an Australian-owned pharmaceutical manufacturer who supply over 65 medicines in critical therapeutic areas to the Australian market, as well as supplying and out-licencing products globally.

Following the vacation of Phebra’s sub-tenant at their Lane Cove West site, there was a desire to expand their existing facility into the adjacent vacated tenancy.

Johnstaff’s role

Johnstaff was engaged by Australia Pacific Consultants (APC), on behalf of Phebra, to provide Construction Management services for expansion of Phebra’s existing facility, without affecting their ongoing operations.

The scope of the project involved the expansion of various areas within Phebra’s existing facility, including slab-to-slab demolition and refurbishment of approximately 1,500m² of office accommodation, expansion of the existing ‘Grade D’ packaging hall into the vacated tenancy, construction of a new laboratory and finished-product storage area, as well as construction of a new non-sterile manufacturing area.

Addressing the issues

Due to Phebra’s requirement for their facility to remain fully-operational throughout the works, careful planning, consultation and co-ordination was required to split the works into stages and various sub-stages. These allowed the works to occur and Phebra to migrate into the newly-completed areas without affecting their ongoing operations. 

Johnstaff worked closely with APC and the specialist trade contractors to manage the programme on Phebra’s behalf, allowing complete client operational flexibility during the delivery phase.

map of the project location


  • Packaging & finished-product storage more than doubled

  • No disruption to existing operations or production output

  • Project split into multiple stages, each with its own sub-stages

  • Provision of new dedicated laboratory and non-sterile manufacturing facilities